Short description
Nanjing Tengchen Biotechnology is a biological company that develops tumour in vitro diagnostic technology and products.
Description
Nanjing Tengchen Biotechnology develops in vitro diagnostic tools and tumour treatment products. The company has secured funding from domestic first-line venture capital institutions and has technology for tumor diagnostics, prognosis evaluation, curative effect evaluation, and recurrence monitoring. As part of an approach in the field of cancer early screening and early diagnosis, they will create early screening and early diagnosis products for lung cancer, breast cancer, prostate cancer, thyroid cancer, esophageal cancer, and pancreatic cancer.
Last funding
Nopepepe
Sign in for full access
Total funding
$$43214321
Sign in for full access
Location
Nanjing, Jiangsu, China, Asia
Founded on
March 1, 2018
Non-profit?
No
Acquired?
No
Employees count
11-50
Investors
Absolutely Noaccess
Sign in for full access